Allarity Therapeutics Inc... (ALLR)
NASDAQ: ALLR
· Real-Time Price · USD
1.17
-0.03 (-2.50%)
At close: May 01, 2025, 3:59 PM
1.16
-0.43%
Pre-market: May 02, 2025, 05:15 AM EDT
-2.50% (1D)
| Bid | 1.15 |
| Market Cap | 19.82M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -25.08M |
| EPS (ttm) | -15.65 |
| PE Ratio (ttm) | -0.07 |
| Forward PE | -0.02 |
| Analyst | n/a |
| Ask | 1.19 |
| Volume | 559,883 |
| Avg. Volume (20D) | 1,997,570 |
| Open | 1.20 |
| Previous Close | 1.20 |
| Day's Range | 1.15 - 1.21 |
| 52-Week Range | 0.61 - 103.80 |
| Beta | -0.07 |
About ALLR
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA, a microt...
Industry Biotechnology
Sector Healthcare
IPO Date Dec 21, 2021
Employees 6
Stock Exchange NASDAQ
Ticker Symbol ALLR
Website https://www.allarity.com
1 month ago
-9.91%
Allarity Therapeutics shares are trading higher af...
Unlock content with
Pro Subscription
2 months ago
+10.19%
Allarity Therapeutics shares are trading higher after the company's board announced a $5 million share repurchase program.
